ETFs Holding AAVL »    AAVL Historical Stock Prices »
AAVL News Video: Fri, Aug 14, 2015, 10:46 AM — Friday Sector Laggards: Biotechnology, Apparel Stores

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Avalanche Biotechnologies is a clinical-stage biotechnology company focused on discovering and developing gene therapies to treat patients with sight-threatening ophthalmic diseases. Co.'s main product candidate is AVA-101 for the treatment of wet age-related macular degeneration (AMD). AVA-101 enables retinal cells to continuously produce therapeutic levels of a naturally occurring anti-vascular endothelial growth factor protein with a single administration. In addition, Co.'s Ocular BioFactory platform has developed AVA-201, a product candidate for the prevention of wet AMD; and AVA-311, which is being evaluated in preclinical studies for the treatment of juvenile X-linked retinoschisis. Self directed investors in Avalanche Biotechnologies, Inc. will be interested in keeping up with all Avalanche Biotechnologies, Inc. news they can find, both AAVL news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on AAVL. At RediNews, we simplify this task by presenting both AAVL news releases originating from Avalanche Biotechnologies, Inc. itself, and AAVL news from a variety of media outlets. Visitors can browse this news online and through our AAVL RSS news feed.


AAVL News — Articles, Videos, & Press Releases

Avalanche (AAVL) Reports Wider-than-Expected Q1 Loss
Monday, May 9, 2016, 8:16 AM — Zacks
Relative Strength Alert For Avalanche Biotechnologies
Friday, May 6, 2016, 12:08 PM — Dividend Channel
Implied IUSG Analyst Target Price: $91
Friday, May 6, 2016, 7:27 AM — ETF Channel
Commit To Buy Avalanche Biotechnologies At $5, Earn 24.1% Annualized Using Options
Tuesday, May 3, 2016, 11:46 AM — Stock Options Channel
Look Under The Hood: IBB Has 56% Upside
Thursday, March 24, 2016, 7:52 AM — ETF Channel
Avalanche (AAVL) Reports Wider-than-Expected Loss in Q4
Friday, March 4, 2016, 8:50 AM — Zacks
Avalanche (AAVL) Posts Wider-than-Expected 4Q Loss
Thursday, March 3, 2016, 8:36 AM — Zacks
What's in Store for Avalanche (AAVL) This Earnings Season?
Wednesday, March 2, 2016, 2:40 PM — Zacks
How The Parts Add Up: UWM Headed For $78
Monday, February 22, 2016, 7:56 AM — ETF Channel
Avalanche Biotechnologies (AAVL) Jumps: Stock Rises 10.1%
Thursday, February 11, 2016, 7:15 AM — Zacks
Avalanche (AAVL) Set to Acquire Annapurna Therapeutics
Tuesday, February 2, 2016, 4:28 PM — Zacks
Commit To Buy Avalanche Biotechnologies At $5, Earn 20.3% Annualized Using Options
Tuesday, January 26, 2016, 11:55 AM — Stock Options Channel
Avalanche Biotechnologies Becomes Oversold (AAVL)
Monday, January 11, 2016, 12:44 PM — Dividend Channel
Noteworthy Wednesday Option Activity: FTK, SMTC, AAVL
Wednesday, December 30, 2015, 11:34 AM — Stock Options Channel
Avalanche (AAVL) Reports Wider-than-Expected Loss in Q3
Tuesday, November 10, 2015, 1:10 PM — Zacks
5 Exciting Biotech Stocks to Buy on November Upswing
Tuesday, November 3, 2015, 10:00 AM — Zacks
Lexicon Presents Positive Data from Telotristat Etiprate Study
Wednesday, September 30, 2015, 3:21 PM — Zacks
Avalanche Biotechnologies (AAVL) is Oversold: Can It Recover?
Tuesday, September 29, 2015, 7:28 AM — Zacks
Avalanche Biotechnologies (AAVL) Q2 Loss Narrows Y/Y
Friday, August 14, 2015, 8:30 AM — Zacks
Company News for June 17, 2015 - Corporate Summary
Wednesday, June 17, 2015, 8:10 AM — Zacks
Company News for May 14, 2015 - Corporate Summary
Thursday, May 14, 2015, 8:10 AM — Zacks
AAVL is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GEN News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AAVL News | | Copyright © 2013 - 2017, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.